MedTrace Logo

Evaluation of Root Coverage After the Use of Coronally Advanced Flap Either With Advanced Paltelet Rich Fibrin or Subepithilial Connective Tissue Graft in Treatment of Miller Class I and II Gingival Recession.

NCT03695549 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2018-10-09

No results posted yet for this study

Summary

patients with Miller class I , II gingival recession will be divided into 2 groups (control, intervention).the control one will receive coronally advanced flap with subepithililal connective tissue graft harvested from the palate while the intervention one will have coronally advanced flap with advanced platelet rich fibrin(A-PRF).as it represent a new generation of platelet concentrate allow for better healing and root coverage results.

Null hypothesis: In patients with Miller class I and II gingival recession, there is no difference in amount of root coverage (mm) following the application of SCTG+A-PRF compared to CAF+SCTG.

Conditions

  • Gingival Recession

Interventions

PROCEDURE

CAF + (A-PRF)

advanced platelet rich fibrin prepared by low speed centrfugation concept(LSCC) together with coronally advanced flap .

PROCEDURE

CAF+SCTG

cornally advanced flap plus subepithilial connective tissue graft harvested from the palate

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Heba Samir Mhmoud, assistant lecturer · Cairo University

  • Manal M Hosny, professor · Cairo University

  • Engi A Mahmoud, assistant professor · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-31
Primary Completion
2019-07-31
Completion
2019-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03695549 on ClinicalTrials.gov